Correspondence: Reply to 'Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury'.

The article focuses on formyl peptide receptors that are involved in ischaemia-reperfusion injury. Topics discussed include the G protein-coupled receptor (GPCR), disease pathologies that affect central nervous systems, inflammation, and metabolism, and small-molecule FPR agonists mechanisms that facilitate FPR-biased strategies.